"ଡେକ୍ସଲାନ୍ସୋପ୍ରାଜୋଲ" ପୃଷ୍ଠାର ସଂସ୍କରଣ‌ଗୁଡ଼ିକ ମଧ୍ୟରେ ତଫାତ

Content deleted Content added
ଅଧିକ ତ‌ଥ୍ୟ ଦିଆଗଲା
ଅଧିକ ତ‌ଥ୍ୟ ଦିଆଗଲା
୫୭ କ ଧାଡ଼ି:
 
<!-- ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟା ଓ କାର୍ଯ୍ୟବିଧି -->
ଡେକ୍ସଲାନ୍ସୋପ୍ରାଜୋଲର ସାଧାରଣ ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟାରେ [[ତରଳ ଝାଡ଼ା]], ଉଦର ଯନ୍ତ୍ରଣା ଓ ଅଇ ହୋଇପାରେ ।<ref name=AHFS2019/> ପାର୍ଶ୍ୱ ପ୍ରତିକ୍ରିୟ ସାଂଘାତିକ ହେଲେ [[ଓଷ୍ଟିଓପୋରୋସିସ]], ଆଦି[[ଅଳ୍ପ ହୋଇପାରେରକ୍ତ ।{{^|ମାଗନେସିଅମ]] Serious([[:en:low sideblood effectsmagnesium|low mayblood include [[osteoporosismagnesium]]), [[lowକ୍ଲସ୍ଟ୍ରିଡିଅମ bloodଡିଫିସିଲ magnesiumସଂକ୍ରମଣ]], ([[:en:Clostridium difficile infection|''Clostridium difficile'' infection]]), [[anaphylaxisଆନାଫାଇଲାକ୍ସିସ]], and [[pneumoniaନିମୋନିଆ]]. ଆଦି ରୋଗ ହୋଇପାରେ ।<ref name=AHFS2019/> Use in [[pregnancyଗର୍ଭାବସ୍ଥା]] and [[breastfeedingସ୍ତନ୍ୟପାନ]] isସମୟରେ ofଏହାର unclearନିରାପତ୍ତା safety.ସନେହ ଜନ‌କ ।<ref name=Preg2019>{{cite web |title=Dexlansoprazole Use During Pregnancy|url=https://www.drugs.com/pregnancy/dexlansoprazole.html |website=Drugs.com |accessdate=3 March 2019 |language=en}}</ref> Itପାକସ୍ଥଳୀର worksପାରାଏଟାଲ byଜୀବକୋଷରେ blocking([[:en:parietal cell|parietal cell]]) ଥିବା [[ହାଇଡ୍ରୋଜେନ ପୋଟାସିଅମ ଏଟିପେଜ]]କୁ ([[:en:Hydrogen potassium ATPase|H<sup>+</sup>/K<sup>+</sup>-ATPase]]) inଅବରୋଧ theକରି [[parietalଏହା cell]]sକାର୍ଯ୍ୟକ୍ଷମ ofହୁଏ the stomach.<ref name=AHFS2019>{{cite web |title=Dexlansoprazole Monograph for Professionals |url=https://www.drugs.com/monograph/dexlansoprazole.html |website=Drugs.com |publisher=American Society of Health-System Pharmacists |accessdate=3 March 2019 |language=en}}</ref>
{{^|
 
<!-- Society and culture -->
Dexlansoprazole was approved for medical use in the United States in 2009.<ref name=AHFS2019/> In the United States the wholesale cost for a month is about 270 USD.<ref name=NADAC2019>{{cite web |title=NADAC as of 2019-02-27 |url=https://data.medicaid.gov/Drug-Pricing-and-Payment/NADAC-as-of-2019-02-27/s7c9-pfa6 |website=Centers for Medicare and Medicaid Services |accessdate=3 March 2019 |language=en}}</ref> In Canada this amount costs about 71.50 CAD in 2016 making it the most expensive PPI avaliable at the time.<ref name=TI2016/> In 2016 it was the 190th most prescribed medication in the United States with more than 3 million prescriptions.<ref>{{cite web |title=The Top 300 of 2019 |url=https://clincalc.com/DrugStats/Top300Drugs.aspx |website=clincalc.com |accessdate=22 December 2018}}</ref>